Searching News Database: Streptococcus pneumoniae
HSMN NewsFeed - 24 May 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
HSMN NewsFeed - 9 Aug 2016
Alere Achieves IVD CE Mark for its Alere(TM) Reader Lateral Flow Assay Analyzer
Alere Achieves IVD CE Mark for its Alere(TM) Reader Lateral Flow Assay Analyzer
HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
HSMN NewsFeed - 19 Nov 2012
Abacus Diagnostica Receives CE Mark for its Rapid Direct PCR Test for Toxigenic Clostridium Difficile
Abacus Diagnostica Receives CE Mark for its Rapid Direct PCR Test for Toxigenic Clostridium Difficile
HSMN NewsFeed - 20 Jun 2011
Genocea Biosciences Hires Ravi Venkataramani, Ph.D. as Vice President, Business Development
Genocea Biosciences Hires Ravi Venkataramani, Ph.D. as Vice President, Business Development
HSMN NewsFeed - 1 Feb 2011
Genocea Biosciences Announces Promotion of Chip Clark to President and Chief Executive Officer
Genocea Biosciences Announces Promotion of Chip Clark to President and Chief Executive Officer
HSMN NewsFeed - 10 Aug 2010
Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia
Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia
HSMN NewsFeed - 16 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
HSMN NewsFeed - 27 Mar 2009
Nabriva Therapeutics Appoints Dr David Chiswell as Chief Executive Officer
Nabriva Therapeutics Appoints Dr David Chiswell as Chief Executive Officer
HSMN NewsFeed - 26 Mar 2009
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
HSMN NewsFeed - 11 Feb 2009
Genocea Biosciences Names Jane Halpern Vice President of Regulatory Affairs
Genocea Biosciences Names Jane Halpern Vice President of Regulatory Affairs
HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences Announces NDA Submission for Cethromycin in Community Acquired Pneumonia
Advanced Life Sciences Announces NDA Submission for Cethromycin in Community Acquired Pneumonia
HSMN NewsFeed - 23 Jul 2008
Vaccine Executive Staph Bakali Joins Genocea Biosciences' Board of Directors
Vaccine Executive Staph Bakali Joins Genocea Biosciences' Board of Directors
HSMN NewsFeed - 13 Aug 2007
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
HSMN NewsFeed - 21 Jun 2007
Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
HSMN NewsFeed - 22 Feb 2007
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
HSMN NewsFeed - 23 Jan 2007
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
HSMN NewsFeed - 14 Dec 2006
Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
HSMN NewsFeed - 29 Jun 2006
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
Additional items found! 62
Members Archive contains
62 additional stories matching:
Streptococcus pneumoniae
(Password required)
Streptococcus pneumoniae
(Password required)